Raj Denhoy
Stock Analyst at Jefferies
(3.07)
# 1,084
Out of 4,829 analysts
55
Total ratings
66.67%
Success rate
24.33%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $131.99 | -9.08% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $74.80 | +73.80% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $58.81 | +87.04% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $4.35 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $85.05 | -63.26% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $11.39 | +207.29% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $129.24 | +128.26% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $45.23 | +101.19% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $79.52 | -66.05% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $316.67 | -78.84% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $131.99
Upside: -9.08%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $74.80
Upside: +73.80%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $58.81
Upside: +87.04%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $4.35
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $85.05
Upside: -63.26%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $11.39
Upside: +207.29%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $129.24
Upside: +128.26%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $45.23
Upside: +101.19%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $79.52
Upside: -66.05%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $316.67
Upside: -78.84%